Different First-line Immunotherapy for Advancer Hepatocellular Carcinoma: A Prospective Observational Study on Efficacy and Immune Microenvironment
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Recurrent/Metastatic Olfactory Neuroblastoma: Evaluating the Efficacy and Safety of Nivolumab
- Status
- RECRUITING
- Phase
- PHASE2
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
- Status
- RECRUITING
- Phase
- N/A
Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer
- Status
- SUSPENDED
- Phase
- PHASE2
Nivo40-AVD for Advanced Classic Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE1
Saci Nivo Rela for TNBC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE4
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
- Status
- RECRUITING
- Phase
- PHASE3
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
- Status
- RECRUITING
- Phase
- PHASE1
Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
- Status
- RECRUITING
- Phase
- PHASE2